Band 5+: The chart below shows how much money five big pharmaceutical companies spent on research in 2012 and 2018 and gives an estimate of the amounts spent in 2022. Describe the data providing an overview of the general trends, reporting the main features, and making comparisons.

The bar chart demostrates the amount of money which five big pharmaceutical companies spent since 2012 till 2022. The data is measured in billion dollars.

Overall, the expenses of all pharmaceutical companies were increasing during the time period. Every company has the same trend of rising but different quantitive values.

On the on hand, Novas had the most amount of spending money in 2022. The value reached almost 60 billion dollars. The data difference between Novas and the company with the second most value of the whole bar chart (Fleming) is consisted of approximately 30 billion dollars! Other companies like Biopharm, Avicenna and Pharm had not significant difference and the values are composed of around 25.

On the other hand, Biopharm had the least value of spending in 2012. The expenses did not exceed even 5 billion dollars. The company had also the least amount of spending money in 2018. Other companies had values around 10 billion and only Avicenna and Pharm had values which were higher than 10.